Intuitive Surgical, Inc. $ISRG Shares Sold by Brookwood Investment Group LLC

Brookwood Investment Group LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.0% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,225 shares of the medical equipment provider’s stock after selling 183 shares during the period. Brookwood Investment Group LLC’s holdings in Intuitive Surgical were worth $666,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Aaron Wealth Advisors LLC lifted its position in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after acquiring an additional 19 shares in the last quarter. FSM Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after purchasing an additional 20 shares during the last quarter. CFO4Life Group LLC increased its holdings in Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 20 shares during the last quarter. J. W. Coons Advisors LLC increased its holdings in Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after purchasing an additional 20 shares during the last quarter. Finally, Exencial Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.1% during the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Rothschild & Co Redburn lifted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Evercore ISI dropped their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a report on Tuesday, October 7th. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Sunday. Daiwa Capital Markets lifted their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $603.38.

Intuitive Surgical Trading Up 0.9%

Shares of NASDAQ ISRG opened at $551.25 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market capitalization of $197.61 billion, a price-to-earnings ratio of 72.92, a price-to-earnings-growth ratio of 5.02 and a beta of 1.61. The business has a 50 day simple moving average of $459.49 and a 200-day simple moving average of $497.31.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the business earned $1.84 EPS. The business’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 88,324 shares of company stock valued at $46,093,939 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.